Form 4: Opko Health Sells Shares of GeneDx Holdings Corp.

Opko Health, a significant shareholder of GeneDx Holdings Corp., has sold a portion of its Class A common stock in two transactions.

Summary

• Opko Health, Inc. sold 75,000 shares of GeneDx Holdings Corp. Class A Common Stock on July 24, 2024, at a weighted average price of $33.7214.
• The prices for these shares ranged from $33.33 to $34.33.
• Following this transaction, Opko Health beneficially owned 3,183,403 shares.
• On July 26, 2024, Opko Health sold an additional 60,000 shares at a weighted average price of $33.8543, with prices ranging from $33.50 to $34.66.
• After the second transaction, Opko Health's beneficial ownership decreased to 3,123,403 shares.

Sentiment

Score: 5

Explanation: The document is a standard SEC Form 4 filing, indicating a change in share ownership. It doesn't inherently convey positive or negative sentiment, but rather reports factual transactions.

Industry Context

This filing indicates a change in ownership stake by a major shareholder, which is a common occurrence in publicly traded companies. The reasons for the sale are not disclosed in the filing and could be for various reasons, including portfolio rebalancing or strategic decisions by Opko Health.

Stakeholder Impact

• The sale of shares by Opko Health could potentially influence the market perception of GeneDx Holdings Corp., although the impact is likely to be minimal given the relatively small volume of shares sold compared to the total outstanding shares.

Key Dates